- Investing Ideas
- /
- Swedish Biotech Stocks
Swedish Biotech Stocks
Results
49
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
49 companies
Swedish Orphan Biovitrum
Market Cap: SEK 96.3b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 277.00
7D
1.0%
1Y
-14.1%
Camurus
Market Cap: SEK 40.5b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 681.50
7D
-1.2%
1Y
7.4%
BioArctic
Market Cap: SEK 25.7b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 289.40
7D
4.9%
1Y
75.4%
Bonesupport Holding
Market Cap: SEK 19.8b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 300.20
7D
0.5%
1Y
1.2%
Vitrolife
Market Cap: SEK 17.2b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 127.30
7D
-2.2%
1Y
-47.5%
BioGaia
Market Cap: SEK 11.0b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 108.60
7D
2.4%
1Y
-4.7%
MedCap
Market Cap: SEK 8.5b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 564.00
7D
-5.8%
1Y
13.5%
Swedencare
Market Cap: SEK 5.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 33.60
7D
-14.9%
1Y
-20.8%
Flerie
Market Cap: SEK 3.3b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 42.00
7D
0.7%
1Y
-1.2%
Vicore Pharma Holding
Market Cap: SEK 2.6b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 11.26
7D
16.3%
1Y
59.9%
Devyser Diagnostics
Market Cap: SEK 2.4b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 145.20
7D
-5.0%
1Y
8.4%
Egetis Therapeutics
Market Cap: SEK 2.0b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.51
7D
2.6%
1Y
31.8%
BioInvent International
Market Cap: SEK 2.0b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
BINV
SEK 30.00
7D
-2.9%
1Y
-36.8%
Saniona
Market Cap: SEK 1.6b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 11.40
7D
1.1%
1Y
146.2%
Genovis AB (publ.)
Market Cap: SEK 1.5b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 22.75
7D
-7.5%
1Y
-13.3%
BICO Group
Market Cap: SEK 1.5b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 21.00
7D
-3.0%
1Y
-48.9%
Oncopeptides
Market Cap: SEK 1.0b
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 4.64
7D
-5.4%
1Y
114.1%
Orexo
Market Cap: SEK 1.0b
A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 30.15
7D
12.5%
1Y
115.7%
Xbrane Biopharma
Market Cap: SEK 667.5m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.26
7D
6.8%
1Y
46.7%
FluoGuide
Market Cap: SEK 513.5m
A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.
FLUO
SEK 37.70
7D
-1.0%
1Y
-7.5%
Moberg Pharma
Market Cap: SEK 403.0m
A pharmaceutical company, develops and commercializes medical products primarily in Sweden.
MOB
SEK 8.58
7D
-3.1%
1Y
-15.9%
Ascelia Pharma
Market Cap: SEK 400.3m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 3.45
7D
-8.2%
1Y
40.2%
Mendus
Market Cap: SEK 369.8m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 7.10
7D
2.7%
1Y
-17.0%
IRLAB Therapeutics
Market Cap: SEK 254.8m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 3.00
7D
0.3%
1Y
-75.1%
Karolinska Development
Market Cap: SEK 241.5m
A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.
KDEV
SEK 0.90
7D
0%
1Y
-25.4%
SenzaGen
Market Cap: SEK 181.7m
Provides non-animal tests for assessing allergenicity.
SENZA
SEK 6.16
7D
6.9%
1Y
-13.8%
Biovica International
Market Cap: SEK 167.4m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.61
7D
-1.0%
1Y
-76.7%
Vivesto
Market Cap: SEK 127.0m
Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.
VIVE
SEK 0.24
7D
6.5%
1Y
-3.3%
Alzinova
Market Cap: SEK 118.7m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 1.14
7D
-1.0%
1Y
-67.3%
NextCell Pharma
Market Cap: SEK 110.3m
A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.
NXTCL
SEK 0.99
7D
-3.3%
1Y
-40.7%
Nanologica
Market Cap: SEK 106.5m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.
NICA
SEK 1.21
7D
0.4%
1Y
-49.8%
Abera Bioscience
Market Cap: SEK 99.8m
A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.
ABERA
SEK 6.50
7D
-18.8%
1Y
64.1%
IDL Diagnostics
Market Cap: SEK 92.1m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.40
7D
-3.1%
1Y
-23.8%
PEPTONIC medical
Market Cap: SEK 92.1m
A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.
PMED
SEK 0.06
7D
0%
1Y
-27.7%
Newbury Pharmaceuticals
Market Cap: SEK 76.9m
Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.
NEWBRY
SEK 2.53
7D
0.8%
1Y
-22.9%
AcouSort
Market Cap: SEK 67.9m
A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
ACOU
SEK 3.21
7D
-4.5%
1Y
-76.9%